Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3Observational 2

Sponsor

Conditions

Psoriasis 7Lymphoma, Follicular 7Bronchiolitis Obliterans Syndrome 7Pruritus 5Arthritis, Rheumatoid 3Plaque, Amyloid 1Myasthenia Gravis 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Glioblastoma 1Cholangiocarcinoma 1Arthritis, Psoriatic 1Adenocarcinoma 1

Interventions

Adalimumab 13Methotrexate 11Etanercept 10Rituximab 5Abatacept 5tocilizumab 4olokizumab 4tofacitinib 3golimumab 3Infliximab 3Tumor Necrosis Factor Inhibitors 2Saline Solution 2RC-18 2Nivolumab 2Leflunomide 2Certolizumab Pegol 2Antirheumatic Agents 2veltuzumab 1upadacitinib 1secukinumab 1sarilumab 1mavrilimumab 1entecavir 1cabozantinib 1baricitinib 1andecaliximab 1Vitamin D 1Vaccines 1TACI receptor-IgG Fc fragment fusion protein 1Syringes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Arthritis, Rheumatoid × tofacitinib × Clear all
NCT03976245 2024-11-29

Advanced Therapeutics in Rheumatoid Arthritis (RA)

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 4 Recruiting
144 enrolled

Arthritis, Rheumatoid

NCT02092467 2021-08-17

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Pfizer

Phase 4 Completed
4,372 enrolled 22 charts

Arthritis, Rheumatoid

NCT00960440 2018-12-19

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Pfizer

Phase 3 Completed
399 enrolled 51 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡